2019 annual financial data
Viridian Therapeutics 2019 Operating margin
Direct answer
Operating margin was -941.02%.
Operating income was -41,979,000 USD and net income was -41,873,000 USD.
Operating cash flow was -36,056,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,461,000 USD
- Operating income
- -41,979,000 USD
- Net income
- -41,873,000 USD
- Operating cash flow
- -36,056,000 USD